Synthesis and biological evaluation of 1-azabicyclo-[3.2.1]octanes: new dopamine transporter inhibitors

Bioorg Med Chem Lett. 2000 Aug 7;10(15):1681-6. doi: 10.1016/s0960-894x(00)00308-5.

Abstract

The synthesis and biological activity of a series of 6-substituted 1-azabicyclo[3.2.1]octanes are described. 1-Azabicyclo[3.2.1]octanes represent a new class of compounds that exhibit monoamine transporter inhibitory activity highly dependent on the overall topology and the absolute stereochemistry of the molecule.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Bridged Bicyclo Compounds, Heterocyclic / chemical synthesis*
  • Bridged Bicyclo Compounds, Heterocyclic / pharmacology*
  • Carrier Proteins / antagonists & inhibitors*
  • Dopamine Plasma Membrane Transport Proteins
  • Membrane Glycoproteins*
  • Membrane Transport Proteins*
  • Models, Molecular
  • Nerve Tissue Proteins*
  • Quantitative Structure-Activity Relationship

Substances

  • Bridged Bicyclo Compounds, Heterocyclic
  • Carrier Proteins
  • Dopamine Plasma Membrane Transport Proteins
  • Membrane Glycoproteins
  • Membrane Transport Proteins
  • Nerve Tissue Proteins